<?xml version='1.0' encoding='utf-8'?>
<document id="16697485"><sentence text="Oral bioavailability of a low molecular weight heparin using a polymeric delivery system." /><sentence text="Low molecular weight heparins (LMWHs) are the standards of anticoagulant for the prevention of deep vein thrombosis (DVT) in patients undergoing arthroplasty and abdominal surgery" /><sentence text=" However, LMWHs are so far only administered by parenteral route" /><sentence text=" Thus, they are usually replaced by oral warfarin for outpatient therapy" /><sentence text=" Since warfarin has a slow onset and high incidence of drug-drug interaction, there is a great need for the development of an oral LMWH formulation"><entity charOffset="7-15" id="DDI-PubMed.16697485.s5.e0" text="warfarin" /></sentence><sentence text=" LMWH (tinzaparin)-loaded nanoparticles prepared with a blend of a polyester and a polycationic polymethacrylate by the double emulsion method were administered orally in fasted rabbits"><entity charOffset="67-76" id="DDI-PubMed.16697485.s6.e0" text="polyester" /><entity charOffset="96-112" id="DDI-PubMed.16697485.s6.e1" text="polymethacrylate" /><pair ddi="false" e1="DDI-PubMed.16697485.s6.e0" e2="DDI-PubMed.16697485.s6.e0" /><pair ddi="false" e1="DDI-PubMed.16697485.s6.e0" e2="DDI-PubMed.16697485.s6.e1" /></sentence><sentence text=" The plasma tinzaparin concentration was measured by a chromogenic anti-factor Xa assay"><entity charOffset="12-22" id="DDI-PubMed.16697485.s7.e0" text="tinzaparin" /></sentence><sentence text=" After oral administration of two doses of tinzaparin-loaded nanoparticles (200 and 600 anti-Xa U/kg), the oral absorption was observed between 4 and 10 or 12 h, with a delayed onset of action ranging from 3 to 4 h"><entity charOffset="43-53" id="DDI-PubMed.16697485.s8.e0" text="tinzaparin" /></sentence><sentence text=" Mean absolute bioavailabilities were 51% and 59% for the two tested doses" /><sentence text=" We now report that the encapsulation of tinzaparin into nanoparticles is likely to contribute to its oral efficacy with an anticoagulant effect prolonged up to 8 h"><entity charOffset="41-51" id="DDI-PubMed.16697485.s10.e0" text="tinzaparin" /></sentence><sentence text="" /></document>